Biotech start - up Prevail Therapeutics has invested $ 500 million to develop a gene therapy for Parkinson 's disease . The ##iot York - based company will invest the money to accelerate clinical testing of an experimental treatment called PR001 , which has been developed to treat a rare variant of the disease .
Biotech start-up Prevail Therapeutics has raised $75m to develop a gene therapy for Parkinson's disease. The New York-based company will use the money to accelerate clinical testing of an experimental treatment called PR001, which has been developed to treat a rare form of the illness.